Hvl Pharma Uk
United Kingdom Updated 9 July 2026
Hvl Pharma Uk is an API manufacturer based in United Kingdom. It holds one active US drug master file. Its GMP standing is certified by MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 3 November 2022 as VAI.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 3 November 2022 VAI US FDA
- 22 July 2019 VAI US FDA
- 6 March 2017 VAI US FDA
- 27 February 2015 NAI US FDA
- 13 April 2011 VAI US FDA
- 13 November 2008 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| HAVERHILL, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3002807062 |
What they file, and where
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MHRA (UK) | None | 6 |
Comparing suppliers?
Choose your molecules and target markets. Hvl Pharma Uk comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 3 November 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates